Tsukuba, Japan

Hirokazu Ohsawa


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Hirokazu Ohsawa

Introduction

Hirokazu Ohsawa, a prominent inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals with a total of four patented inventions. His work focuses on developing compounds that exhibit potent pharmacological activities, particularly in treating various diseases.

Latest Patents

Ohsawa's latest inventions include innovative derivatives that address crucial health issues. One of his key patents is for N-acyl cyclic amine derivatives, which are characterized by their selective antagonistic activity against muscarinic M3 receptors. These compounds are designed to be effective remedies for respiratory, urinary, and digestive diseases, providing a dual benefit of efficacy and minimal adverse side effects.

Another noteworthy patent from Ohsawa involves fluorine-containing 1,4-disubstituted piperidine derivatives. This invention details the process of synthesizing these derivatives through reactions between carboxylic acids and piperidine derivatives, resulting in highly effective pharmaceuticals.

Career Highlights

Hirokazu Ohsawa is currently associated with Banyu Pharmaceutical Co. Ltd, where he utilizes his expertise to advance pharmacological innovations. His inventive work has significantly influenced the development of safer and more effective medications.

Collaborations

Throughout his career, Ohsawa has worked alongside respected colleagues, including Yoshimi Tsuchiya and Takashi Nomoto. These collaborations have contributed to the successful realization of his patented inventions, showcasing the importance of teamwork in the innovative process.

Conclusion

Hirokazu Ohsawa exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only enhance our understanding of chemical compounds but also offer promising solutions for various medical challenges. As he continues his work at Banyu Pharmaceutical Co. Ltd, Ohsawa's contributions will undoubtedly pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…